Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
C1 Inhibitor for Severe Traumatic Brain Injury
NCT04489160Phase 2Unknown
- Sponsor
- Leiden University Medical Center
- Start
- Feb 2021
- Primary completion
- Jul 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of c1-esterase inhibitor in traumatic brain injury (TBI), sponsored by Leiden University Medical Center. Status: unknown.
02
Drugs
c1-esterase inhibitor
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT04489160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04489160.